Search research articles
Contact Us
Filters
Showing results (81-90 of 346) with videos related to
Page
of 35
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
December 3, 2019
Risk of Infection Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Somedeb Ball, Avash Das, Wasawat Vutthikraivit, et al.
Leukemia & Lymphoma
|
January 19, 2023
Sudden lymphoid blast crisis after tyrosine kinase inhibitor discontinuation in chronic phase chronic myeloid leukemia: cautionary tales for appropriate molecular monitoring
Alex Bataller, Fadi G Haddad, Ghayas C Issa, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 8, 2026
Evolving Paradigms in the Treatment of Philadelphia Chromosome-Positive ALL
Nicholas J Short, Josep-Maria Ribera, Iman Abou Dalle, et al.
Acta Haematologica
|
April 4, 2024
Failure of Treatment-Free Remission after a Prolonged Deep Molecular Response in Patients with Chronic Myeloid Leukemia
Patrice E Nasnas, Elias J Jabbour, Koji Sasaki, et al.
Leukemia & Lymphoma
|
March 8, 2017
Quality and cost comparison of powered versus manual bone marrow biopsy devices in patients with myelofibrosis
Abhishek Maiti, Nicholas J Short, Srdan Verstovsek, et al.
Cancer
|
April 5, 2021
De novo acute myeloid leukemia: A population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017
Koji Sasaki, Farhad Ravandi, Tapan M Kadia, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 11, 2025
A Phase I/II Trial of Ruxolitinib with Chemotherapy for Patients with Relapsed and/or Refractory Philadelphia-like Acute Lymphoblastic Leukemia
Hannah Goulart, Elias Jabbour, Nicholas J Short, et al.
Cancer
|
July 29, 2015
Fludarabine, cyclophosphamide, and multiple-dose rituximab as frontline therapy for chronic lymphocytic leukemia
Nicholas J Short, Michael J Keating, William G Wierda, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 28, 2021
Acute Myeloid Leukemia: Historical Perspective and Progress in Research and Therapy Over 5 Decades
Hagop M Kantarjian, Nicholas J Short, Amir T Fathi, et al.
American Journal of Hematology
|
August 17, 2024
Secondary acquisition of the Philadelphia chromosome in acute lymphoblastic leukemia
Qiudan Shen, Elias J Jabbour, Guilin Tang, et al.
Page
of 35
Search research articles
Search
Showing results (81-90 of 346) with videos related to
Sort By:
Page
of 35
Clinical Lymphoma, Myeloma & Leukemia
|
December 3, 2019
Risk of Infection Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Somedeb Ball, Avash Das, Wasawat Vutthikraivit, et al.
Leukemia & Lymphoma
|
January 19, 2023
Sudden lymphoid blast crisis after tyrosine kinase inhibitor discontinuation in chronic phase chronic myeloid leukemia: cautionary tales for appropriate molecular monitoring
Alex Bataller, Fadi G Haddad, Ghayas C Issa, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 8, 2026
Evolving Paradigms in the Treatment of Philadelphia Chromosome-Positive ALL
Nicholas J Short, Josep-Maria Ribera, Iman Abou Dalle, et al.
Acta Haematologica
|
April 4, 2024
Failure of Treatment-Free Remission after a Prolonged Deep Molecular Response in Patients with Chronic Myeloid Leukemia
Patrice E Nasnas, Elias J Jabbour, Koji Sasaki, et al.
Leukemia & Lymphoma
|
March 8, 2017
Quality and cost comparison of powered versus manual bone marrow biopsy devices in patients with myelofibrosis
Abhishek Maiti, Nicholas J Short, Srdan Verstovsek, et al.
Cancer
|
April 5, 2021
De novo acute myeloid leukemia: A population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017
Koji Sasaki, Farhad Ravandi, Tapan M Kadia, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 11, 2025
A Phase I/II Trial of Ruxolitinib with Chemotherapy for Patients with Relapsed and/or Refractory Philadelphia-like Acute Lymphoblastic Leukemia
Hannah Goulart, Elias Jabbour, Nicholas J Short, et al.
Cancer
|
July 29, 2015
Fludarabine, cyclophosphamide, and multiple-dose rituximab as frontline therapy for chronic lymphocytic leukemia
Nicholas J Short, Michael J Keating, William G Wierda, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 28, 2021
Acute Myeloid Leukemia: Historical Perspective and Progress in Research and Therapy Over 5 Decades
Hagop M Kantarjian, Nicholas J Short, Amir T Fathi, et al.
American Journal of Hematology
|
August 17, 2024
Secondary acquisition of the Philadelphia chromosome in acute lymphoblastic leukemia
Qiudan Shen, Elias J Jabbour, Guilin Tang, et al.
Page
of 35